Get started
Author

Xiaoqian Liu

Observed name: X H Liu
ORCID: 0000-0001-8951-6940
Observed ORCID: 0000-0001-8951-6940
OpenAlex ID: A5028228145
Mycobacterium tuberculosis manipulates LINC02528 in macrophages to modulate anti-tuberculosis metabolic immunity
2025 · Yuzhong Xu, Kehong Zhang, et al. · PLoS Pathogens · 8
PDF
[Observation on the efficacy of consolidation chemotherapy combined with allogeneic natural killer cell infusion in the treatment of low and moderate risk acute myeloid leukemia].
2019 · C J Wang, X J Huang, et al. · PubMed Central · 8
PDF
Elliptinium, norcantharidin and tetrachlordecaoxide in combined chemo-immunotherapy prolong the survival of Friend-virus-infected mice.
1991 · X H Liu, I Blazsek, et al. · PubMed · 3
Exploring the molecular properties and bactericidal potential of Lysin B from mycobacteriophage WXIN
2026 · Jiaxin Li, Jingjing Li, et al. · BMC Microbiology · 1
Supplemental Figure S6 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Supplemental Figure S4 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Supplemental Figure S5 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Supplemental Figure S1 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Supplemental Figure S8 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Supplemental Table S1 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Supplemental Figure S3 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Supplemental Figure S2 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Supplemental Figure S7 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Supplemental Table S2 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Supplemental Figure S9 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Supplemental Table S3 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Data from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2026 · Cassandra L. Moyer, Jamal L. Hill, et al.
Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
2025 · Cassandra L. Moyer, Jamal L. Hill, et al. · Cancer Prevention Research
PDF
Works count: 18
Citation count: 20
H-index: 3
I10-index:
Year
Topic
Type